Control arms are key to reliably determining whether a new treatment works better than what already exists. The data they generate – from trial patients who receive a placebo, the standard of care (SO ...
Control arms are key to reliably determining whether a new treatment works better than what already exists. The data they generate – from trial patients who receive a placebo, the standard of care (SO ...
How two distinct, yet complementary approaches could revolutionize R&D Mechanistic modeling and artificial intelligence (AI) are both transforming medicine. AI is being increasingly applied to drug ...
As technology spreads across healthcare, the trust question becomes more urgent. Should we trust what a digital health app tells us? Can we rely on a diagnosis provided by an algorithm? Can drug devel ...
It’s a red-hot question: how to bridge the gap between available and desired levels of evidence for a drug’s safety and efficacy? [FDA’s approval](https://www.fda.gov/news-events/press-announcements/f ...
No clinical trial is perfect. The gold-standard randomized controlled trial does a good job of trying to be, but we know its flaws: selection isn’t truly random, conditions often don’t reflect patient ...